<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>OBJECTIVE: To develop a sensitive method to detect <z:e sem="disease" ids="C0242596" disease_type="Neoplastic Process" abbrv="MRD">minimal residual disease</z:e> and to elucidate the significance of bcl-2 gene rearrangement in diagnosis and therapy of malignant <z:hpo ids='HP_0002665'>lymphoma</z:hpo> </plain></SENT>
<SENT sid="1" pm="."><plain>METHODS: Using polymerase chain reaction(PCR) to detect bcl-2 gene rearrangement and using serial dilution method to define the sensitivity of PCR </plain></SENT>
<SENT sid="2" pm="."><plain>RESULTS: In 9 different malignant <z:hpo ids='HP_0002665'>lymphoma</z:hpo> cell lines, Su-DHL-4 and Su-DHL-6 were shown bcl-2(MBR)/JH rearrangement, the sensitivity of PCR was 1:10(5) </plain></SENT>
<SENT sid="3" pm="."><plain>In 16 patients with follicular <z:hpo ids='HP_0002665'>lymphoma</z:hpo>, the peripheral blood and bone marrow were PCR positive in 4 both at initial diagnosis and after complete remission </plain></SENT>
<SENT sid="4" pm="."><plain>CONCLUSION: Detection of bcl-2 gene rearrangement by PCR provides a sensitive and specific assay of <z:e sem="disease" ids="C0242596" disease_type="Neoplastic Process" abbrv="MRD">minimal residual disease</z:e> </plain></SENT>
<SENT sid="5" pm="."><plain>It helps improve staging of disease, stratification and evaluation of treatment </plain></SENT>
</text></document>